Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

Johnson and Johnson

Last Updated: July 4, 2020

DrugPatentWatch Database Preview

Usl Pharma Company Profile

Email this page to a colleague

» See Plans and Pricing

« Back to Dashboard

What is the competitive landscape for USL PHARMA, and what generic and branded alternatives to USL PHARMA drugs are available?

USL PHARMA has one hundred and three approved drugs.

Summary for Usl Pharma
US Patents:0

Drugs and US Patents for Usl Pharma

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Usl Pharma HYDROCORTISONE hydrocortisone CREAM;TOPICAL 088027-001 Sep 27, 1983 DISCN No No   Start Trial   Start Trial
Usl Pharma CHLORDIAZEPOXIDE HYDROCHLORIDE chlordiazepoxide hydrochloride CAPSULE;ORAL 084623-001 Approved Prior to Jan 1, 1982 DISCN No No   Start Trial   Start Trial
Usl Pharma IMIPRAMINE HYDROCHLORIDE imipramine hydrochloride TABLET;ORAL 087776-001 Feb 10, 1982 DISCN No No   Start Trial   Start Trial
Usl Pharma MECLOFENAMATE SODIUM meclofenamate sodium CAPSULE;ORAL 071007-001 Mar 25, 1988 DISCN No No   Start Trial   Start Trial
Usl Pharma BACLOFEN baclofen TABLET;ORAL 071260-001 May 6, 1988 DISCN No No   Start Trial   Start Trial
Usl Pharma ACETAMINOPHEN AND CODEINE PHOSPHATE acetaminophen; codeine phosphate TABLET;ORAL 087920-001 Jun 22, 1982 DISCN No No   Start Trial   Start Trial
Usl Pharma HYDROFLUMETHIAZIDE AND RESERPINE hydroflumethiazide; reserpine TABLET;ORAL 088195-001 Oct 26, 1983 DISCN No No   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Harvard Business School
Express Scripts

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.